Amplitude Surgical – Consolidated Annual Sales of €95.5 Million, +10% at Constant Exchange Rates - Seite 2

France

62,391

55,227

13.0%

13.0%

International

33,110

33,059

0.2%

5.2%

of which: subsidiaries

25,192

24,292

3.7%

10.5%

of which: distributors

7,919

8,767

-9.7%

-9.6%

Total

95,502

88,286

8.2%

10.0%

Over its 2020-21 financial year to June 30, 2021, Amplitude Surgical recorded sales of €95.5 million, up 8.2% in actual terms and 10.0% at constant currency. Activity was significantly impacted on most of the Group’s markets from October 2020 by the situation associated with COVID-19, with restrictions on access to operating rooms resulting in the postponement of scheduled surgical procedures. However, the impact was lower for the Group than it was following the almost total shutdown of all activity in the final quarter of the previous year.

During the final quarter of the recently ended financial year, Amplitude Surgical’s activity was up by 86.8% at constant currency.

• In France, annual sales totaled €62.4 million, up +13%. During the year, activity was negatively impacted from the second quarter by the successive waves of the COVID-19 pandemic, while the previous year the negative impact only affected the final quarter of the year, albeit to a greater extent. France accounted for 64% of total annual sales;

• The Group’s international activity generated sales of €33.1 million, a slight increase of 0.2% in actual terms and 5.2% at constant currency. The Group’s subsidiaries recorded growth of 10.5% at constant currency to €25.2 million. Subsidiaries’ activity was notably negatively impacted by the public health situation associated with COVID-19 in Brazil and Germany and by the shutdown in the Group’s activity in Japan, while Novastep’s activity in the United States recorded strong growth. Activity with the Group’s distributors fell by 9.6% to €7.9 million;

• Amplitude Surgical’s direct business (French market and international subsidiaries), which accounts for almost 92% of the Group’s total sales, increased by 12.2% at constant currency;

• Novastep, innovative solutions for foot and ankle surgery, saw its annual sales further increase to €12.8 million (+53.5% at constant currency). Novastep’s activity accounted for 13.4% of total Group sales.

Next financial press release